Product Development

Merck KGaA’s bintrafusp alfa miss suggests there’s still more to learn about TGFβ

Phase III miss in NSCLC raises questions about the hypothesis that TGFβ can help overcome checkpoint resistance

Phase III miss in NSCLC raises questions about the hypothesis that TGFβ can help overcome checkpoint resistance. 

The Phase III miss for Merck KGaA’s